此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Communication With in Vitro Fertilization (IVF) Patients About Risks

2016年11月22日 更新者:University of Kansas Medical Center

Improving Communication With IVF Patients About Risks Such as Multiple Births

The primary objective of this trial is to determine whether written educational materials plus brief education by telephone will help patients better understand and participate in the decision on how many embryos to transfer to the uterus during treatment of infertility with in vitro fertilization (IVF). The main study hypothesis is that women and men who receive the study's educational intervention will experience favorable changes in knowledge and beliefs about benefits, susceptibility and severity of multiple gestation that impact decisions about the number of embryos to transfer. Secondary objectives are to understand patient beliefs, knowledge and information preferences regarding other possible risks of IVF, to compare perception of IVF-related risks to familiar risks that are included in routine preconception health promotion, and during IVF, and to prepare couples to manage IVF-related obstetrical risks when they make the transition to prenatal care after becoming pregnant.

Medical Treatment Coverage: None, this study does not provide any monetary contribution to medical treatment

研究概览

详细说明

The long-term objective of this research is to improve patient understanding of the known and strongly suspected risks from treating infertility with assisted reproductive technologies such as in vitro fertilization (IVF). During IVF, when more embryos are transferred to the uterus, the risk of pregnancy with multiple fetuses increases. In addition, single infants conceived with IVF are at greater risk for low birth weight. This study will promote behaviors that may reduce these risks. One in 3 women who completes a pregnancy conceived with assisted reproductive technologies such as IVF delivers multiples, and these treatments produce over 12,000 multiple birth deliveries annually in the United States. This study will lead to a better understanding of the most effective ways to counsel IVF patients about the embryo transfer decision. This study will also help define how to prepare IVF patients to work most effectively with their prenatal care team to manage IVF-related obstetrical risks.

Medical Treatment Coverage: None, this study does not provide any monetary contribution to medical treatment

研究类型

介入性

注册 (实际的)

264

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Kansas
      • Wichita、Kansas、美国、67214
        • University of Kansas School of Medicine

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • At least 18 years of age

Exclusion Criteria:

  • Using a gestational carrier in the current cycle of IVF

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Intervention
Written materials, telephone based education
4 new written materials, 15-20 minute educational session by telephone
其他:Comparison
Written materials
2 written materials available on public website

研究衡量的是什么?

主要结果指标

结果测量
大体时间
questionnaire assessing knowledge, risk perception, self efficacy and preferences, interview about risk perception and decision making
大体时间:Prior to IVF treatment cycle, 8 weeks
Prior to IVF treatment cycle, 8 weeks

次要结果测量

结果测量
大体时间
Adoption of healthy preconception behavior, self-efficacy for addressing IVF related obstetrical factors
大体时间:Prior to IVF treatment cycle, 8 weeks
Prior to IVF treatment cycle, 8 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Linda Frazier, MD、University of Kansas School of Medicine-Wichita

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2007年9月1日

初级完成 (实际的)

2010年2月1日

研究完成 (实际的)

2010年5月1日

研究注册日期

首次提交

2008年7月23日

首先提交符合 QC 标准的

2008年7月24日

首次发布 (估计)

2008年7月25日

研究记录更新

最后更新发布 (估计)

2016年11月25日

上次提交的符合 QC 标准的更新

2016年11月22日

最后验证

2016年11月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • 220060957
  • 1R21HD053459-01A1 (美国 NIH 拨款/合同)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅